3DDF image
Deposition Date 2008-06-05
Release Date 2008-07-01
Last Version Date 2024-11-20
Entry Detail
PDB ID:
3DDF
Keywords:
Title:
GOLGI MANNOSIDASE II complex with (3R,4R,5R)-3,4-Dihydroxy-5-({[(1R)-2-hydroxy-1 phenylethyl]amino}methyl) pyrrolidin-2-one
Biological Source:
Source Organism:
Method Details:
Experimental Method:
Resolution:
1.20 Å
R-Value Free:
0.15
R-Value Work:
0.11
R-Value Observed:
0.11
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:alpha-mannosidase 2
Gene (Uniprot):alpha-Man-IIa
Chain IDs:A
Chain Length:1045
Number of Molecules:1
Biological Source:Drosophila melanogaster
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
ASN A ASN GLYCOSYLATION SITE
Primary Citation
Functionalized pyrrolidine inhibitors of human type II alpha-mannosidases as anti-cancer agents: optimizing the fit to the active site
Bioorg.Med.Chem. 16 7337 7346 (2008)
PMID: 18599296 DOI: 10.1016/j.bmc.2008.06.021

Abstact

Refining the chemical structure of functionalized pyrrolidine-based inhibitors of Golgi alpha-mannosidase II (GMII) to optimize binding affinity provided a lead molecule that demonstrated nanomolar competitive inhibition of alpha-mannosidases II and an optimal fit in the active site of Drosophila GMII by X-ray crystallography. Esters of this lead compound also inhibited the growth of human glioblastoma and brain-derived endothelial cells more than the growth of non-tumoral human fibroblasts, suggesting their potential for anti-cancer therapy.

Legend

Protein

Chemical

Disease

Primary Citation of related structures